Clinical Audit Assessment of compliance to follow-up schedule following PRP in patients with Proliferative Diabetic Retinopathy Department of Retina and.

Slides:



Advertisements
Similar presentations
1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy.
Advertisements

The Diabetic Retinopathy Clinical Research Network
Evan (Jake) Waxman MD PhD
The Diabetic Retinopathy Clinical Research Network Effects of Intravitreal Ranibizumab or Triamcinolone on Diabetic Retinopathy Jennifer K. Sun, MD, MPH.
DIABETES AND THE EYE. EPIDEMIOLOGY Commonest cause of blindness in the population of working age in developed countries Prevalence of DR of any severity.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
Vitrectomy Outcomes in Eyes with Diabetic Macular Edema, Visual Loss, and Vitreomacular Traction Sponsored by the National Eye Institute, National Institutes.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Macular Edema After Cataract Surgery Diabetic Retinopathy Clinical Research Network.
Diabetic Retinopathy Clinical Research Network
Diabetic Retinopathy Norma Maddox Donna Charlotte.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Framework for Designing effective DR Programs Thulasiraj Ravilla LAICO – Aravind Eye Care System.
The Diabetic Retinopathy Clinical Research Network
Personalised Eye Consultation (PEC) to improve outcomes in DR Dr Eva Fenwick (Research Fellow) Behavioural Research in Ophthalmology Prue Spencer, Project.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Diabetes and the Eyes Kenyon Anderson, O.D.. Blindness Risk Diabetic eye disease, caused by diabetes, is a leading cause of blindness and vision loss.
RIDER 33/CHAPTER 261 COMPLIANCE AUDITS. What is it? The legal requirement to report abuse (sexual or other abuse) of children The rules include reporting.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 6.
Eye problem in patients with Diabetes. Retina Cornea Lens Macula Optic Nerve DIFFERENT PARTS OF THE EYE.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
OSCE Objective Structured Clinical Examination For Fourth Class Students In Internal Medicine Department By: Mohammad Maroof “Aram” MD, Associated Professor.
OPHTHALMOLOGY DIABETES
The Diabetic Retinopathy Clinical Research Network
Josephine Carlos-Raboca, M.D. Makati Medical Center
Diabetic Eye diseases Diabetic Retinopathy Saad… Sheharyar Pervaiz Sheikh Usman Sadiq… Muhammad Maqbool Ahmed
The Diabetic Retinopathy Clinical Research Network DRCR.net Prompt PRP vs Ranibizumab+Deferred PRP for PDR Study Jeffrey G. Gross, M.D. – Protocol Chair.
Vitrase (Hyaluronidase for Injection) Advisory Committee Meeting March 17, 2003 Jennifer D. Harris, MD Medical Officer Division of Anti-inflammatory, Analgesic,
Old Fibrotic Vascular tissue in End-Stage Proliferative Retinopathy
How Diabetes Steals Vision from Your Patients
The Diabetic Retinopathy Clinical Research Network
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Inhibition of Neovascularization but Not Fibrosis.
Retinal Detachment Success Rates for Alberta
Annual Diabetic conference-2016
Glossophobia.
Classification and treatment of Diabetic Retinopathy
Copyright © 2012 American Medical Association. All rights reserved.
The Diabetic Retinopathy Clinical Research Network
A Novel approach for Enhancing management of chronic eye conditions -lessons from piloting cloud based registries in primary eye care centres in south.
DEPARTMENT OF COUNSELLING
Presentation Dr Lyn Jenkins, Clinical Director Ophthalmology
Andrew A. Moshfeghi, MD, MBA, Howard Shapiro, PhD, Linda A
1 Maidstone and Tunbridge Wells NHS Trust (Kent Oncology Centre)
Aravind Eye Hospital Theni Medical Records Department
The Diabetic Retinopathy Clinical Research Network
Quality Indicators Oct, Nov, Dec
3. Background diabetic retinopathy
Welcome To All 18-Sep-18.
F.Fazel,MD. F.Fazel,MD The treatment of Diabetic Retinopathy.
Randomized Clinical Trial Jeffrey G. Gross, M.D. for the DRCR Network
DESIGN ISSUES OF A NON-INFERIORITY TRIAL
DIABETES AND THE EYE.
Tornado diagram for net monetary benefit usual care (usual care) versus intervention (early PRP). Tornado diagram for net monetary benefit usual care (usual.
The Diabetic Retinopathy Clinical Research Network
Endocarditis Prevention Advice Audit
The Diabetic Retinopathy Clinical Research Network
January 16, 2019.
Annual Diabetic conference-2016
DRCRnet Rationale and Clinical Application of the DRCR.net Anti-VEGF Treatment Algorithm for Proliferative Diabetic Retinopathy Jennifer K. Sun, MD, MPH.
Sabaydee.
Diabetic Retinopathy Clinical Research Network
Prompt PRP vs. Ranibizumab + Deferred PRP for PDR Study
Diabetic Retinopathy Clinical Research Network
DRCR Retina Network Treatment for Center-Involved DME in Eyes with Good Visual Acuity (Protocol V)
FLAME Lecture: 13 Marshburn
The Diabetic Retinopathy Clinical Research Network
Diabetic Retinopathy Clinical Research Network
Global retinal oxygen saturation in eyes with progression or non-progression of proliferative diabetic retinopathy (PDR) before and after panretinal laser.
The Diabetic Retinopathy Clinical Research Network
Presentation transcript:

Clinical Audit Assessment of compliance to follow-up schedule following PRP in patients with Proliferative Diabetic Retinopathy Department of Retina and Vitreous Aravind Eye Hospital, Madurai Audit Period: October, 2016 Auditing person: Dr Jayant Kumar

BACKGROUND Proliferative diabetic retinopathy patients need regular follow-up on a monthly basis following Panretinal Photocoagulation (PRP) The patients may need additional PRP if the follow-up of these patients reveals the need and thus timely follow-up can prove critical in salvaging vision of the patients and avoiding surgery or progression of the disease.

Why this assessment ? We noticed in our OPD that a lot of PDR patients lost to follow-up immediately following PRP. We have done this clinical audit to come up with the exact figures of patients who get lost to follow-up so that corrective measures can be planned

Methodology Study period: October, 2016 The case sheets of all the patients who first underwent PRP for PDR in the month of October, 2016 were reviewed The follow-up following laser procedure should be 100 % as per our standards.

Results 124 patients underwent PRP for PDR in the month of October, 2016 for the first time 107 patients were regular in their follow-up schedule following the laser procedure 17 patients lost to follow-up and did not present for the following 3 months

Discussion The results denote that around 13% of PDR patients in our clinic probably are of the opinion that the end of laser therapy is the end of their treatment regimen and hence do not comply to the follow-up schedule.

Corrective measure: PRP Completion Form A new PRP COMPLETION FORM has been introduced as a corrective measure to improve follow-up. Next Audit to assess its impact: April 2017

Thank You